• Osicent 80mg (Osimertinib):| Targeted Therapy For Lung Cancer Quick View
    • Osicent 80mg (Osimertinib):| Targeted Therapy For Lung Cancer Quick View

    • Osicent 80mg (Osimertinib):| Targeted Therapy For Lung Cancer

    • Osicent 80mg (Osimertinib) is a groundbreaking medication designed for the treatment of non-small cell lung cancer (NSCLC) in patients with specific epidermal growth factor receptor (EGFR) mutations, including the resistant T790M mutation. As a third-generation EGFR inhibitor, Osicent 80mg offers a targeted approach that is proven to be effective in treating advanced and metastatic stages of NSCLC, particularly when the…
    • Read more